Yazid Bounab, Osmo Antikainen, Mia Sivén, Anne Juppo
{"title":"Advancing Direct Tablet Compression with AI: A multi-task framework for quality control, batch acceptance, and causal analysis","authors":"Yazid Bounab, Osmo Antikainen, Mia Sivén, Anne Juppo","doi":"10.1016/j.ejps.2025.107142","DOIUrl":null,"url":null,"abstract":"<div><div>Pharmaceutical manufacturing has surged in drug development with the rise of Pharma 4.0, leveraging artificial intelligence (AI) to improve efficiency, optimize resource use, and reduce production times. Direct Tablet Compression (DTC), a key manufacturing technique, depends on the physicochemical properties of active pharmaceutical ingredients (API), excipients, and process parameters. This paper presents a novel multi-task framework combining regression, classification, and text generation to predict tablet properties (friability, hardness, disintegration time, and water absorption ratio), determine batch acceptance, and provide insights for optimizing interactions to improve tablet quality. The framework not only enables real-time monitoring, quality control and regulatory compliance, but also helps to understand the reasons why tablets in the manufacturing batch do not meet quality requirements. Using statistical methods, Neural Networks (NN), Natural Language Processing (NLP), and generative AI (GenAI), it outperforms state-of-the-art methods, achieving 91.8% <span><math><msup><mrow><mi>R</mi></mrow><mrow><mn>2</mn></mrow></msup></math></span> and 95.5% accuracy for regression and classification, respectively, as demonstrated using the Harvard Dataverse V1 dataset of Fast Disintegrating Tablets (FDTs) non placebo.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"212 ","pages":"Article 107142"},"PeriodicalIF":4.7000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928098725001411","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Pharmaceutical manufacturing has surged in drug development with the rise of Pharma 4.0, leveraging artificial intelligence (AI) to improve efficiency, optimize resource use, and reduce production times. Direct Tablet Compression (DTC), a key manufacturing technique, depends on the physicochemical properties of active pharmaceutical ingredients (API), excipients, and process parameters. This paper presents a novel multi-task framework combining regression, classification, and text generation to predict tablet properties (friability, hardness, disintegration time, and water absorption ratio), determine batch acceptance, and provide insights for optimizing interactions to improve tablet quality. The framework not only enables real-time monitoring, quality control and regulatory compliance, but also helps to understand the reasons why tablets in the manufacturing batch do not meet quality requirements. Using statistical methods, Neural Networks (NN), Natural Language Processing (NLP), and generative AI (GenAI), it outperforms state-of-the-art methods, achieving 91.8% and 95.5% accuracy for regression and classification, respectively, as demonstrated using the Harvard Dataverse V1 dataset of Fast Disintegrating Tablets (FDTs) non placebo.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.